FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting

Study limitation reported by the research below: “Recommendations are derived from a European panel and may not reflect regulatory or practice contexts outside Europe.”